Skip to content
Back to Investors
DCVC

DCVC

Venture Capital

Portfolio

5

companies

Investment by month

By category

  • AI/ML£118M
  • Quantum Computing£118M
  • BioTech£20.0M

By location

  • London£205M
  • Cambridge£50.4M

Portfolio companies

C

Callosum

Callosum builds software that distributes artificial intelligence tasks across heterogeneous chips and models to improve inference efficiency.

E

Evonetix

Evonetix builds semiconductor technology platforms for desktop DNA synthesis.

L

Lumafield

Lumafield builds accessible X-ray CT scanners and analysis software for engineers.

QM

Quantum Motion

Quantum Motion builds silicon transistor-based quantum computers designed for standard data-centre racks.

Recycleye

Recycleye

Recycleye develops artificial intelligence and robotics to automate waste sorting.


Team

KC

Kelly Chen

Partner

Prineha Narang

Prineha Narang

Operating Partner

Prineha serves as an operating partner at DCVC and a professor at the University of California, Los Angeles. She also holds board and advisory roles with Caltech, arXiv, and ScienceCast.org.

LinkedIn

Recent investments

Seed
$100M

Atomico led the financing alongside Plural, DCVC, and the UK Sovereign AI Fund.

"By integrating Cerebras into Callosum’s platform, we’re making ultra-low-latency inference available exactly where it creates the greatest impact, enabling customers to build AI systems that simply weren’t practical before,"
— Andrew Feldman
Series C
£118M

The funding round was co-led by DCVC and Kembara with participation from the British Business Bank and Firgun.

"Today's announcement reflects the strength of the team we have built and the progress they have delivered. Quantum computing will only achieve its full potential if it can be built on a platform that scales, and we believe silicon is the strongest route to achieving that. We are pleased to be joined by investors who share our vision and understand what it takes to build a foundational company in this field."
— James Palles-Dimmock, CEO
Series B
£20.0M

The oversubscribed round included backing from Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence.

"This substantial investment round demonstrates continued confidence in the progress of our technical development and its potential to revolutionise the accessibility of gene synthesis. Evonetix is in a very exciting phase, having recently opened our early access program. This investment will support us as we execute on our commercial strategy to put benchtop gene synthesis in the hands of users."
— Colin McCracken, Chief Executive Officer
Series A
£14.0M

DCVC led the Series A round to support the scale up of artificial intelligence waste sorting systems.

"At FCC, we believe in being forward-thinking, so investing in the latest waste sorting technology was an obvious choice. Recycleye Robotics is delivering the consistent purity in sorted material and reliable data that we need to run an effective facility"
— Rory Brien